SPRO Spero Therapeutics, Inc.
Healthcare · Pharmaceutical Preparations · Market cap: $58.2M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $3.4M | $0 |
| 2022-Q2 | $208.2K | $0 |
| 2022-Q3 | $0 | $4.3M |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $52.3K |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $74.0K |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $318.0K |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $57.3K |
| 2024-Q4 | $0 | $53.0K |
| 2025-Q1 | $0 | $235.4K |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $16.3K |
| 2025-Q4 | $0 | $95.4K |
| 2026-Q1 | $0 | $393.2K |
| 2026-Q2 | $0 | $63.4K |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $42.5K |
Bought$7.4M12 buy days
Sold$5.8M41 sell days
Net insider flow+$1.6Mnet buying · 5 years
Latest trade2026-11-09Rajavelu Esther
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-11-09 | Sell | Rajavelu Esther | Director | 40,851 | $1.04 | $42.5K | 1 |
| 2026-05-04 | Sell | Rajavelu Esther | Other officer | 25,240 | $2.51 | $63.4K | 1 |
| 2026-02-06 | Sell | Rajavelu Esther | Other officer | 87,917 | $2.36 | $207.5K | 2 |
| 2026-02-06 | Sell | Keutzer Timothy | COO | 18,652 | $2.36 | $44.0K | 1 |
| 2026-02-04 | Sell | Keutzer Timothy | COO | 3,471 | $2.24 | $7.8K | 1 |
| 2026-02-03 | Sell | Keutzer Timothy | COO | 24,224 | $2.14 | $51.8K | 1 |
| 2026-02-02 | Sell | Keutzer Timothy | COO | 18,891 | $2.20 | $41.6K | 1 |
| 2026-02-02 | Sell | Rajavelu Esther | Other officer | 18,442 | $2.20 | $40.6K | 1 |
| 2025-11-07 | Sell | Rajavelu Esther | Other officer | 40,270 | $2.37 | $95.4K | 1 |
| 2025-08-28 | Sell | Mahadevia Ankit | Director | 6,572 | $1.97 | $12.9K | 1 |
| 2025-08-28 | Sell | Keutzer Timothy | COO | 1,695 | $1.97 | $3.3K | 1 |
| 2025-02-05 | Sell | Shukla Sath | CEO | 155,333 | $0.78 | $121.2K | 3 |
| 2025-02-05 | Sell | Mahadevia Ankit | Director | 69,219 | $0.78 | $54.0K | 2 |
| 2025-02-05 | Sell | Keutzer Timothy | COO | 56,537 | $0.78 | $44.1K | 3 |
| 2025-02-05 | Sell | Rajavelu Esther | CFO | 20,689 | $0.78 | $16.1K | 1 |
| 2024-11-08 | Sell | Rajavelu Esther | CFO | 17,245 | $1.30 | $22.4K | 1 |
| 2024-11-07 | Sell | Rajavelu Esther | CFO | 23,351 | $1.31 | $30.6K | 1 |
| 2024-08-27 | Sell | Mahadevia Ankit | Director | 5,912 | $1.35 | $8.0K | 1 |
| 2024-08-27 | Sell | Shukla Sath | CEO | 2,757 | $1.35 | $3.7K | 1 |
| 2024-08-27 | Sell | Keutzer Timothy | COO | 2,213 | $1.35 | $3.0K | 1 |
| 2024-08-05 | Sell | Shukla Sath | CEO | 17,641 | $1.31 | $23.1K | 1 |
| 2024-08-02 | Sell | Shukla Sath | CEO | 14,800 | $1.32 | $19.5K | 1 |
| 2024-02-05 | Sell | Shukla Sath | CEO | 45,093 | $1.45 | $65.4K | 1 |
| 2024-02-02 | Sell | Mahadevia Ankit | Director | 63,795 | $1.37 | $87.4K | 1 |
| 2024-02-02 | Sell | JOSEPH TAMARA L | Other C-suite | 30,906 | $1.37 | $42.3K | 1 |
| 2024-02-02 | Sell | Shukla Sath | CEO | 30,901 | $1.37 | $42.3K | 1 |
| 2024-02-02 | Sell | Keutzer Timothy | COO | 30,971 | $1.36 | $42.1K | 1 |
| 2024-02-02 | Sell | HAMED KAMAL | Other C-suite | 28,075 | $1.37 | $38.5K | 1 |
| 2023-09-13 | Sell | HAMED KAMAL | Other C-suite | 39,496 | $1.27 | $50.2K | 1 |
| 2023-08-29 | Sell | Shukla Sath | CEO | 4,163 | $1.30 | $5.4K | 1 |
| 2023-08-28 | Sell | Mahadevia Ankit | Director | 9,040 | $1.26 | $11.4K | 1 |
| 2023-08-28 | Sell | Shukla Sath | CEO | 1,854 | $1.26 | $2.3K | 1 |
| 2023-08-28 | Sell | JOSEPH TAMARA L | Other C-suite | 1,854 | $1.26 | $2.3K | 1 |
| 2023-08-28 | Sell | Keutzer Timothy | Other C-suite | 1,854 | $1.26 | $2.3K | 1 |
| 2023-02-03 | Sell | Mahadevia Ankit | CEO | 12,286 | $1.81 | $22.2K | 1 |
| 2023-02-02 | Sell | Shukla Sath | CFO | 9,504 | $1.83 | $17.4K | 1 |
| 2023-02-02 | Sell | Keutzer Timothy | COO | 3,394 | $1.86 | $6.3K | 1 |
| 2023-02-02 | Sell | JOSEPH TAMARA L | Other C-suite | 3,394 | $1.86 | $6.3K | 1 |
| 2022-09-22 | Sell | Aquilo Capital, L.P. | 10% owner | 1,901,796 | $2.25 | $4.3M | 2 |
| 2022-08-29 | Sell | Shukla Sath | CFO | 6,017 | $0.89 | $5.4K | 1 |
| 2022-04-26 | Buy | Aquilo Capital, L.P. | 10% owner | 39,727 | $5.24 | $208.2K | 1 |
| 2022-03-30 | Buy | Aquilo Capital, L.P. | 10% owner | 50,000 | $8.79 | $439.5K | 2 |
| 2022-03-14 | Buy | Aquilo Capital, L.P. | 10% owner | 23,708 | $7.63 | $180.9K | 2 |
| 2022-02-28 | Buy | Aquilo Capital, L.P. | 10% owner | 44,833 | $9.53 | $427.3K | 2 |
| 2022-02-18 | Buy | Aquilo Capital, L.P. | 10% owner | 14,828 | $9.24 | $137.0K | 1 |
| 2022-01-31 | Buy | Aquilo Capital, L.P. | 10% owner | 125,000 | $11.59 | $1.4M | 1 |
| 2022-01-24 | Buy | Aquilo Capital, L.P. | 10% owner | 1,599 | $10.89 | $17.4K | 1 |
| 2022-01-18 | Buy | Aquilo Capital, L.P. | 10% owner | 48,488 | $12.41 | $601.7K | 1 |
| 2022-01-10 | Buy | Aquilo Capital, L.P. | 10% owner | 8,867 | $12.93 | $114.7K | 1 |
| 2021-12-31 | Buy | Aquilo Capital, L.P. | 10% owner | 125,000 | $15.75 | $2.0M | 1 |
| 2021-12-30 | Buy | Aquilo Capital, L.P. | 10% owner | 50,000 | $15.77 | $788.5K | 1 |
| 2021-12-29 | Buy | Aquilo Capital, L.P. | 10% owner | 75,493 | $14.64 | $1.1M | 1 |
| 2021-12-27 | Sell | Mahadevia Ankit | CEO | 8,000 | $14.58 | $116.6K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Aquilo Capital, L.P. | 10% owner | $7.4M | $4.3M | 2022-09-22 |
| Rajavelu Esther | Director | $0 | $518.5K | 2026-11-09 |
| Mahadevia Ankit | Director | $0 | $312.6K | 2025-08-28 |
| Shukla Sath | CEO | $0 | $305.7K | 2025-02-05 |
| Keutzer Timothy | COO | $0 | $246.4K | 2026-02-06 |
| HAMED KAMAL | Other C-suite | $0 | $88.6K | 2024-02-02 |
| JOSEPH TAMARA L | Other C-suite | $0 | $51.0K | 2024-02-02 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2017-11-06 | 6 | $21.1M | 50 | -18.9% (-16.1% raw) | -6.3% (-5.1% raw) | -9.8% (-3.8% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.